All Stories

  1. Metabolic pathway analysis reveals hierarchical pentose sugar utilization and metabolic flexibility of Bifidobacterium longum
  2. Adaptations and Community Changes in Milk and Water Kefir Microbiomes in Response to Environmental Parameters as Revealed by the Kefir4All Project
  3. Investigating the role of bacterial raw milk community members in chlorate reduction
  4. A technical feasibility study evaluating sustainable enzyme‐based cleaning‐in‐place (CIP) for removal of milk deposits formed on stainless steel surfaces during cheesemilk pasteurisation
  5. Exploring the Functional Potential of the Broiler Gut Microbiome Using Shotgun Metagenomics
  6. Breastfeeding and the milk resistome shape the establishment and transmission of antibiotic resistance genes in the infant gut microbiome
  7. Effects of feeding a simulated waste milk on growth, health, fecal microbiota, and antibiotic resistance in dairy heifer calves
  8. Stress and depression risk in pregnancy associates with altered immune function
  9. Investigating the role of bacterial raw milk community members in chlorate reduction
  10. Development of a modular test bed for evaluating sustainable CIP strategies and fouling removal during milk pasteurisation for cheese production
  11. Strain-level variation among vaginal Lactobacillus crispatus and Lactobacillus iners as identified by comparative metagenomics
  12. The core microbiomes and associated metabolic potential of water kefir as revealed by pan multi-omics
  13. Bactofencin A Displays a Delayed Killing Effect on a Clinical Strain of Staphylococcus aureus Which Is Greatly Accelerated in the Presence of Nisin
  14. A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal...
  15. Author Correction: Examining the healthy human microbiome concept
  16. Investigating the Bioactivities of a Dextran and Levan Mixture Produced by the Sourdough-Derived Leuconostoc mesenteroides Strain DSA_F
  17. Gut MicrobiotAware: how much do we know about gut microbiota? An international questionnaire
  18. Bifidobacterium fermentum sp. nov. and Bifidobacterium aquikefiricola sp. nov., isolated from water kefir
  19. Examining the healthy human microbiome concept
  20. Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxon
  21. Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications
  22. The changing landscape with respect to scientific research and education for second-level students and how they can overlap: the Kefir4All example
  23. Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients
  24. Pseudocin 196, a novel lantibiotic produced by Bifidobacterium pseudocatenulatum elicits antimicrobial activity against clinically relevant pathogens
  25. Novel Dairy Fermentates Have Differential Effects on Key Immune Responses Associated with Viral Immunity and Inflammation in Dendritic Cells
  26. Cataloging metagenome-assembled genomes and microbial genes from the athlete gut microbiome
  27. GROND: a quality-checked and publicly available database of full-length 16S-ITS-23S rRNA operon sequences
  28. Comparative Metagenomics of Vaginal Microbiomes Reveal Strain-Level Differences with Relevance to Colonization and Host-Microbe Interactions
  29. Two extracellular α-arabinofuranosidases are required for cereal-derived arabinoxylan metabolism by Bifidobacterium longum subsp. longum
  30. Kefir4All, a citizen science initiative to raise awareness of the roles that microbes play in food fermentation
  31. Novel Fermentates Can Enhance Key Immune Responses Associated with Viral Immunity
  32. Seasonal and geographical impact on the Irish raw milk microbiota correlates with chemical composition and climatic variables
  33. Novel Dairy Fermentates Have Differential Effects on Key Immune Responses Associated with Viral Immunity and Inflammation
  34. Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics
  35. Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyond
  36. Novel Fermentates Can Enhance Key Immune Responses Associated with Viral Immunity
  37. Development of Fluid Handling Capabilities for Autonomous Sampling Capsule
  38. The impact of live dietary microbes on health: A scoping review
  39. Fermented foods and gastrointestinal health: underlying mechanisms
  40. Profiling of vaginal Lactobacillus jensenii isolated from preterm and full-term pregnancies reveals strain-specific factors relating to host interaction
  41. Associations between the postpartum uterine and vaginal microbiota and the subsequent development of purulent vaginal discharge vary with dairy cow breed and parity
  42. Use of reconstituted kefir consortia to determine the impact of microbial composition on kefir metabolite profiles
  43. Analysis of the milk kefir pan-metagenome reveals four community types, core species, and associated metabolic pathways
  44. Microbiome Interconnectedness throughout Environments with Major Consequences for Healthy People and a Healthy Planet
  45. The impact of live dietary microbes on health: a scoping review
  46. Amplicon-Based High-Throughput Sequencing Method for Genotypic Characterization of Norovirus in Oysters
  47. Differences in Faecal Microbiome Taxonomy, Diversity and Functional Potential in a Bovine Cohort Experimentally Challenged with Mycobacterium avium subsp. paratuberculosis (MAP)
  48. Mapping the available evidence on the impact of ingested live microbes on health: a scoping review protocol
  49. Comprehensive insight into the alterations in the gut microbiome and the intestinal barrier as a consequence of iron deficiency anaemia
  50. Comparison of the relative impacts of acute consumption of an inulin-enriched diet, milk kefir or a commercial probiotic product on the human gut microbiome and metabolome
  51. Benchmarking Bioinformatic Tools for Amplicon-Based Sequencing of Norovirus
  52. Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway
  53. Development of an amplicon-based high throughput sequencing method for genotypic characterisation of norovirus in oysters
  54. The Athlete Gut Microbiome and its Relevance to Health and Performance: A Review
  55. Human gut homeostasis and regeneration: the role of the gut microbiota and its metabolites
  56. Arbuscular Mycorrhiza Support Plant Sulfur Supply through Organosulfur Mobilizing Bacteria in the Hypho- and Rhizosphere
  57. Bioinformatic approaches for studying the microbiome of fermented food
  58. Recruiting and Engaging Women of Reproductive Age with Obesity: Insights from A Mixed-Methods Study within A Trial
  59. The Application of Metagenomics to Study Microbial Communities and Develop Desirable Traits in Fermented Foods
  60. FANGORN: A quality-checked and publicly available database of full-length 16S-ITS-23S rRNA operon sequences
  61. Using Shotgun Sequencing to Describe the Changes Induced by In-Feed Zinc Oxide and Apramycin in the Microbiomes of Pigs One Week Postweaning
  62. Use of Probiotic Bacteria and Bacteriocins as an Alternative to Antibiotics in Aquaculture
  63. Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model
  64. A Graph-Based Molecular Communications Model Analysis of the Human Gut Bacteriome
  65. Gut Steroids and Microbiota: Effect of Gonadectomy and Sex
  66. African fermented foods: overview, emerging benefits, and novel approaches to microbiome profiling
  67. An oxidation resistant pediocin PA-1 derivative and penocin A display effective anti- Listeria activity in a model human gut environment
  68. Identification of Gut Bacteria such as Lactobacillus johnsonii that Disseminate to Systemic Tissues of Wild Type and MyD88–/– Mice
  69. Seasonality and Geography Have a Greater Influence than the Use of Chlorine-Based Cleaning Agents on the Microbiota of Bulk Tank Raw Milk
  70. Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions
  71. Recreating pink defect in cheese with different strains of Thermus bacteria
  72. Editorial: Bacteriocins and Other Ribosomally Synthesised and Post-translationally Modified Peptides (RiPPs) as Alternatives to Antibiotics
  73. Depletion of the gut microbiota differentially affects the impact of whey protein on high‐fat diet‐induced obesity and intestinal permeability
  74. MAP, Johne’s disease and the microbiome; current knowledge and future considerations
  75. Protein quality and quantity influence the effect of dietary fat on weight gain and tissue partitioning via host-microbiota changes
  76. Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine
  77. Bio-Engineered Nisin with Increased Anti-Staphylococcus and Selectively Reduced Anti-Lactococcus Activity for Treatment of Bovine Mastitis
  78. Porcine reproductive and respiratory syndrome virus impacts on gut microbiome in a strain virulence‐dependent fashion
  79. Assessing the ability of nisin A and derivatives thereof to inhibit gram-negative bacteria from the genus Thermus
  80. The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study
  81. In vitro–in vivo Validation of Stimulatory Effect of Oat Ingredients on Lactobacilli
  82. Microbiome-based environmental monitoring of a dairy processing facility highlights the challenges associated with low microbial-load samples
  83. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods
  84. Comparison of the carotenoid profiles of commonly consumed smear-ripened cheeses
  85. The microbiome of deep-sea fish reveals new microbial species and a sparsity of antibiotic resistance genes
  86. Investigating the Role of Diet and Exercise in Gut Microbe-Host Cometabolism
  87. Fermented-Food Metagenomics Reveals Substrate-Associated Differences in Taxonomy and Health-Associated and Antibiotic Resistance Determinants
  88. Antimicrobial use and production system shape the fecal, environmental, and slurry resistomes of pig farms
  89. Shotgun sequencing of the vaginal microbiome reveals both a species and functional potential signature of preterm birth
  90. Outbreak of acute larval cyathostominosis – A “perfect storm” of inflammation and dysbiosis
  91. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
  92. Gut microbes from the phylogenetically diverse genusEubacteriumand their various contributions to gut health
  93. Meta-analysis of cheese microbiomes highlights contributions to multiple aspects of quality
  94. Kefir microbial composition is a deciding factor in the physiological impact of kefir in a mouse model of obesity
  95. Maternal and infant factors that shape neonatal gut colonization by bacteria
  96. The effects of sustained fitness improvement on the gut microbiome: A longitudinal, repeated measures case-study approach
  97. Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome
  98. Tracking the Dairy Microbiota from Farm Bulk Tank to Skimmed Milk Powder
  99. Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL ...
  100. Antifungal Peptides as Therapeutic Agents
  101. Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk
  102. The association between the maternal diet and the maternal and infant gut microbiome: a systematic review
  103. Distinct microbiome composition and metabolome exists across subgroups of elite Irish athletes
  104. The impact of probiotic supplementation on metabolic health in healthy women of reproductive age: a systematic review
  105. Metabolic phenotyping of the human microbiome
  106. Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk
  107. First evidence of production of the lantibiotic nisin P
  108. Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis
  109. Caprine milk fermentation enhances the antithrombotic properties of cheese polar lipids
  110. The Potential Impact of Probiotics on the Gut Microbiome of Athletes
  111. Improvement of Feed Efficiency in Pigs through Microbial Modulation via Fecal Microbiota Transplantation in Sows and Dietary Supplementation of Inulin in Offspring
  112. Four men in a boat: Ultra-endurance exercise alters the gut microbiome
  113. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
  114. Diversity and composition of the gut microbiota of Atlantic salmon ( Salmo salar ) farmed in Irish waters
  115. Porcine Feed Efficiency-Associated Intestinal Microbiota and Physiological Traits: Finding Consistent Cross-Locational Biomarkers for Residual Feed Intake
  116. Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir
  117. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components
  118. Brevibacillus laterosporus strains BGSP7, BGSP9 and BGSP11 isolated from silage produce broad spectrum multi-antimicrobials
  119. Influence of the Intestinal Microbiota on Colonization Resistance to Salmonella and the Shedding Pattern of Naturally Exposed Pigs
  120. Biofilms in Food Processing Environments: Challenges and Opportunities
  121. The dynamics of the antibiotic resistome in the feces of freshly weaned pigs following therapeutic administration of oxytetracycline
  122. Multiparametric liquid biopsy analysis in metastatic prostate cancer
  123. Dietary α-lactalbumin alters energy balance, gut microbiota composition and intestinal nutrient transporter expression in high-fat diet-fed mice
  124. The effect of ovine milk fermentation on the antithrombotic properties of polar lipids
  125. Lactobacillus gasseri APC 678 Reduces Shedding of the Pathogen Clostridium difficile in a Murine Model
  126. Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial
  127. Short-term consumption of a high-fat diet increases host susceptibility to Listeria monocytogenes infection
  128. Bioengineering Nisin to overcome the Nisin Resistance Protein
  129. Functional Characterization of the Lactolisterin BU Gene Cluster of Lactococcus lactis subsp. lactis BGBU1-4
  130. In silico Prediction and Exploration of Potential Bacteriocin Gene Clusters Within the Bacterial Genus Geobacillus
  131. The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn’s Disease and Ulcerative Colitis
  132. The rumen microbiome: a crucial consideration when optimising milk and meat production and nitrogen utilisation efficiency
  133. Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: METAnnotatorX
  134. The potency of the broad spectrum bacteriocin, bactofencin A, against staphylococci is highly dependent on primary structure, N-terminal charge and disulphide formation
  135. Mesophilic Sporeformers Identified in Whey Powder by Using Shotgun Metagenomic Sequencing
  136. A Diverse Range of Human Gut Bacteria Have the Potential To Metabolize the Dietary Component Gallic Acid
  137. Heterologous Expression of Biopreservative Bacteriocins With a View to Low Cost Production
  138. Genomic Characterization of Sulphite Reducing Bacteria Isolated From the Dairy Production Chain
  139. Effect of milk centrifugation and incorporation of high heat-treated centrifugate on the microbial composition and levels of volatile organic compounds of Maasdam cheese
  140. Oral Delivery of Nisin in Resistant Starch Based Matrices Alters the Gut Microbiota in Mice
  141. Sequencing of the Cheese Microbiome and Its Relevance to Industry
  142. Early Salmonella Typhimurium infection in pigs disrupts Microbiome composition and functionality principally at the ileum mucosa
  143. A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults
  144. Fighting biofilms with lantibiotics and other groups of bacteriocins
  145. Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis
  146. Gut microbiota as a source of novel antimicrobials
  147. Species classifier choice is a key consideration when analysing low-complexity food microbiome data
  148. Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring
  149. The intestinal protist Blastocystis is not a common member of the healthy infant gut microbiota in a Westernized country (Ireland)
  150. Post-weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis
  151. Novel insights into the microbiology of fermented dairy foods
  152. Omics-Based Insights into Flavor Development and Microbial Succession within Surface-Ripened Cheese
  153. Build the Read: A Hands-On Activity for Introducing Microbiology Students to NGS and Bioinformatics.
  154. Genome Sequence of Geobacillus stearothermophilus DSM 458, an Antimicrobial-Producing Thermophilic Bacterium, Isolated from a Sugar Beet Factory
  155. Plantaricyclin A, a Novel Circular Bacteriocin Produced by Lactobacillus plantarum NI326: Purification, Characterization, and Heterologous Production
  156. Application of bacteriocin-producing Enterococcus faecium isolated from donkey milk, in the bio-control of Listeria monocytogenes in fresh whey cheese
  157. Lack of Heterogeneity in Bacteriocin Production Across a Selection of Commercial Probiotic Products
  158. Metagenome-based surveillance and diagnostic approaches to studying the microbial ecology of food production and processing environments
  159. Bacteriocin with broad spectrum of activity
  160. Crop Establishment Practices Are a Driver of the Plant Microbiota in Winter Oilseed Rape (Brassica napus)
  161. High-throughput metataxonomic characterization of the raw milk microbiota identifies changes reflecting lactation stage and storage conditions
  162. Use of enhanced nisin derivatives in combination with food-grade oils or citric acid to control Cronobacter sakazakii and Escherichia coli O157:H7
  163. The Fungal Frontier: A Comparative Analysis of Methods Used in the Study of the Human Gut Mycobiome
  164. Whole-Genome Shotgun Sequence of Salmonella bongori, First Isolated in Northwestern Italy
  165. Whey protein effects on energy balance link the intestinal mechanisms of energy absorption with adiposity and hypothalamic neuropeptide gene expression
  166. Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
  167. Strain-Level Metagenomic Analysis of the Fermented Dairy Beverage Nunu Highlights Potential Food Safety Risks
  168. Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli
  169. Exploring a Possible Link between the Intestinal Microbiota and Feed Efficiency in Pigs
  170. The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles
  171. A Profile Hidden Markov Model to investigate the distribution and frequency of LanB-encoding lantibiotic modification genes in the human oral and gut microbiome
  172. Erratum to: The altered gut microbiota in adults with cystic fibrosis
  173. Insights into the Mode of Action of the Sactibiotic Thuricin CD
  174. Forgotten fungi—the gut mycobiome in human health and disease
  175. Health benefits of fermented foods: microbiota and beyond
  176. Drunk bugs: Chronic vapour alcohol exposure induces marked changes in the gut microbiome in mice
  177. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level
  178. The altered gut microbiota in adults with cystic fibrosis
  179. Translating Omics to Food Microbiology
  180. Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model
  181. Correction for Walsh et al., Microbial Succession and Flavor Production in the Fermented Dairy Beverage Kefir
  182. Detection and Enumeration of Spore-Forming Bacteria in Powdered Dairy Products
  183. ‘Microbes in sport’ – The potential role of the gut microbiota in athlete health and performance
  184. Gut microbiota: implications for sports and exercise medicine
  185. Preface to the Fourth Edition
  186. Microbiome Changes During Ripening
  187. Microbiota of Raw Milk and Raw Milk Cheeses
  188. A Bioengineered Nisin Derivative, M21A, in Combination with Food Grade Additives Eradicates Biofilms of Listeria monocytogenes
  189. Short bowel syndrome (SBS)-associated alterations within the gut-liver axis evolve early and persist long-term in the piglet model of short bowel syndrome
  190. Impacts of Seasonal Housing and Teat Preparation on Raw Milk Microbiota: a High-Throughput Sequencing Study
  191. Prevalence and genetic diversity of Blastocystis in family units living in the United States
  192. Bacteriocin production: a relatively unharnessed probiotic trait?
  193. Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation
  194. New Weapons to Fight Old Enemies: Novel Strategies for the (Bio)control of Bacterial Biofilms in the Food Industry
  195. Microbial Succession and Flavor Production in the Fermented Dairy Beverage Kefir
  196. The bacteriocin bactofencin A subtly modulates gut microbial populations
  197. Miscanthus biochar promotes growth of spring barley and shifts bacterial community structures including phosphorus and sulfur mobilizing bacteria
  198. Thermus and the Pink Discoloration Defect in Cheese
  199. 16S rRNA gene sequencing of mock microbial populations- impact of DNA extraction method, primer choice and sequencing platform
  200. The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells
  201. Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on the development of diabetes in a streptozotocin rat model
  202. The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir
  203. In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms
  204. Bacteriocins: Novel Solutions to Age Old Spore-Related Problems?
  205. Compromised Lactobacillus helveticus starter activity in the presence of facultative heterofermentative Lactobacillus casei DPC6987 results in atypical eye formation in Swiss-type cheese
  206. Comparative Genomic Analysis Reveals a Diverse Repertoire of Genes Involved in Prokaryote-Eukaryote Interactions within the Pseudovibrio Genus
  207. Draft Genome Sequence of Lactobacillus casei DPC6800, an Isolate with the Potential to Diversify Flavor in Cheese
  208. Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis
  209. FoodMicrobionet: A database for the visualisation and exploration of food bacterial communities based on network analysis
  210. Somatic/gonadal mosaicism for structural autosomal rearrangements: female predominance among carriers of gonadal mosaicism for unbalanced rearrangements
  211. A novel method of microsatellite genotyping-by-sequencing using individual combinatorial barcoding
  212. Detection of presumptive Bacillus cereus in the Irish dairy farm environment
  213. Value of Microbial Genome Sequencing for Probiotic Strain Identification and Characterization
  214. The Prevalence and Control of Bacillus and Related Spore-Forming Bacteria in the Dairy Industry
  215. Compared to casein, bovine lactoferrin reduces plasma leptin and corticosterone and affects hypothalamic gene expression without altering weight gain or fat mass in high fat diet fed C57/BL6J mice
  216. Bioengineering Lantibiotics for Therapeutic Success
  217. High-throughput DNA sequencing to survey bacterial histidine and tyrosine decarboxylases in raw milk cheeses
  218. Re: Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
  219. Correction: N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota
  220. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood
  221. Generation of the antimicrobial peptide caseicin A from casein by hydrolysis with thermolysin enzymes
  222. N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota
  223. In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database
  224. Impact of Environmental Factors on Bacteriocin Promoter Activity in Gut-Derived Lactobacillus salivarius
  225. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour
  226. Bovine serum albumin as the dominant form of dietary protein reduces subcutaneous fat mass, plasma leptin and plasma corticosterone in high fat-fed C57/BL6J mice
  227. The Sactibiotic Subclass of Bacteriocins: An Update
  228. Biotechnological applications of functional metagenomics in the food and pharmaceutical industries
  229. Bioengineering of the model lantibiotic nisin
  230. Nisin H Is a New Nisin Variant Produced by the Gut-Derived Strain Streptococcus hyointestinalis DPC6484
  231. Development and Application of a Blastocystis Subtype-Specific PCR Assay Reveals that Mixed-Subtype Infections Are Common in a Healthy Human Population
  232. Evaluation of Lactococcus lactis Isolates from Nondairy Sources with Potential Dairy Applications Reveals Extensive Phenotype-Genotype Disparity and Implications for a Revised Species
  233. Antimicrobial antagonists against food pathogens: a bacteriocin perspective
  234. The metabolic role of the microbiota
  235. A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
  236. Lantibiotic Resistance
  237. Exercise and the microbiota
  238. Proteomics as the final step in the functional metagenomics study of antimicrobial resistance
  239. Anaerobic sporeformers and their significance with respect to milk and dairy products
  240. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice
  241. Engineered nisin variants control Listeria in food
  242. Temporal and Spatial Differences in Microbial Composition during the Manufacture of a Continental-Type Cheese
  243. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers
  244. Changes in the colon microbiota and intestinal cytokine gene expression following minimal intestinal surgery
  245. Streptozotocin-induced type-1-diabetes disease onset in Sprague–Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity
  246. Bacteriocin Mining in Metagenomes
  247. Marine Pseudovibrio sp. as a Novel Source of Antimicrobials
  248. The potential for emerging therapeutic options forClostridium difficileinfection
  249. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease
  250. Exopolysaccharide-Producing Probiotic Lactobacilli Reduce Serum Cholesterol and Modify Enteric Microbiota in ApoE-Deficient Mice1,2
  251. Identification of Aminoglycoside and β-Lactam Resistance Genes from within an Infant Gut Functional Metagenomic Library
  252. The microbial eukaryoteBlastocystisis a prevalent and diverse member of the healthy human gut microbiota
  253. Author response: linking lifestyle and microbes
  254. Fermented beverages with health-promoting potential: Past and future perspectives
  255. Exercise and associated dietary extremes impact on gut microbial diversity
  256. An ‘Upp'-turn in bacteriocin receptor identification
  257. Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate
  258. Heterologous Expression of Thuricin CD Immunity Genes in Listeria monocytogenes
  259. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples
  260. Beneficial modulation of the gut microbiota
  261. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice
  262. Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences Energy Balance and the Gut Microbiota In C57BL/6J Mice
  263. A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota
  264. Atypical Listeria innocua strains possess an intact LIPI-3
  265. Generation of Nonpolar Deletion Mutants in Listeria monocytogenes Using the “SOEing” Method
  266. In Silico Assigned Resistance Genes Confer Bifidobacterium with Partial Resistance to Aminoglycosides but Not to Β-Lactams
  267. Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
  268. Interactions between gut microbiota, food and the obese host
  269. Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
  270. Sequence-Based Analysis of the Intestinal Microbiota of Sows and Their Offspring Fed Genetically Modified Maize Expressing a Truncated Form of Bacillus thuringiensis Cry1Ab Protein (Bt Maize)
  271. Tn6188 - A Novel Transposon in Listeria monocytogenes Responsible for Tolerance to Benzalkonium Chloride
  272. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
  273. Sequence-based analysis of the microbial composition of water kefir from multiple sources
  274. The complex microbiota of raw milk
  275. The microbial content of raw and pasteurized cow milk as determined by molecular approaches
  276. Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources
  277. Bacteriocin production by Bifidobacterium spp. A review
  278. Bacterial Communities Established in Bauxite Residues with Different Restoration Histories
  279. Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge
  280. Subtilomycin: A New Lantibiotic from Bacillus subtilis Strain MMA7 Isolated from the Marine Sponge Haliclona simulans
  281. Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome
  282. Analysis of Anti-Clostridium difficile Activity of Thuricin CD, Vancomycin, Metronidazole, Ramoplanin, and Actagardine, both Singly and in Paired Combinations
  283. Strategies to improve the bacteriocin protection provided by lactic acid bacteria
  284. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
  285. Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity
  286. Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity
  287. Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants
  288. Microbial Composition of Human Appendices from Patients following Appendectomy
  289. The individual-specific and diverse nature of the preterm infant microbiota
  290. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
  291. Additions and corrections
  292. Antimicrobials
  293. In vivo activity of Nisin A and Nisin V against Listeria monocytogenes in mice
  294. Microbial production of bacteriocins for use in foods
  295. Nucleic acid-based approaches to investigate microbial-related cheese quality defects
  296. The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
  297. Bacteriocin Mining in Metagenomes
  298. Bacteriocins — a viable alternative to antibiotics?
  299. Bioengineering
  300. Assessment of the Bacteriocinogenic Potential of Marine Bacteria Reveals Lichenicidin Production by Seaweed-Derived Bacillus spp.
  301. Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
  302. Lantibiotic Production by Pathogenic Microorganisms
  303. High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin
  304. Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI
  305. High-Throughput Sequencing for Detection of Subpopulations of Bacteria Not Previously Associated with Artisanal Cheeses
  306. Supernumerary marker chromosomes derived from chromosome 6: Cytogenetic, molecular cytogenetic, and array CGH characterization
  307. The Effect of Feeding Bt MON810 Maize to Pigs for 110 Days on Intestinal Microbiota
  308. Lacticin 3147 - Biosynthesis, Molecular Analysis, Immunity, Bioengineering and Applications
  309. Composition of the early intestinal microbiota
  310. The gut microbiota and its relationship to diet and obesity
  311. Impact of leucine on energy balance
  312. A comparison of methods used to extract bacterial DNA from raw milk and raw milk cheese
  313. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota
  314. High-Throughput Sequence-Based Analysis of the Intestinal Microbiota of Weanling Pigs Fed Genetically Modified MON810 Maize Expressing Bacillus thuringiensis Cry1Ab (Bt Maize) for 31 Days
  315. Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria
  316. Cronobacter spp. in Powdered Infant Formula
  317. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity
  318. Assessing the Contributions of the LiaS Histidine Kinase to the Innate Resistance of Listeria monocytogenes to Nisin, Cephalosporins, and Disinfectants
  319. Technological characterization of bacteriocin producing Lactococcus lactis strains employed to control Listeria monocytogenes in Cottage cheese
  320. Bioengineered nisin derivatives with enhanced activity in complex matrices
  321. Extensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change
  322. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
  323. Antimicrobial Peptides as Therapeutic Agents
  324. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
  325. The Lantibiotic Lacticin 3147 Prevents Systemic Spread ofStaphylococcus aureusin a Murine Infection Model
  326. Homologues and Bioengineered Derivatives of LtnJ Vary in Ability to Form D-Alanine in the Lantibiotic Lacticin 3147
  327. ThespiFEGLocus in Streptococcus infantarius subsp. infantarius BAA-102 Confers Protection against Nisin U
  328. Molecular approaches to analysing the microbial composition of raw milk and raw milk cheese
  329. Bacteriocin Production: a Probiotic Trait?
  330. Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva
  331. Production of Multiple Bacteriocins from a Single Locus by Gastrointestinal Strains of Lactobacillus salivarius
  332. Flagging flora: help from bacteriocins?
  333. Streptolysin S-like virulence factors: the continuing sagA
  334. Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters
  335. High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain
  336. An International Network for Improving Health Properties of Food by Sharing our Knowledge on the Digestive Process
  337. Bacteriocins as Natural Antilisterial Food Preservatives
  338. The impact of nisin on sensitive and resistant mutants of Listeria monocytogenes in cottage cheese
  339. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract
  340. Small intestine and microbiota
  341. Further Identification of Novel Lantibiotic Operons Using LanM-Based Genome Mining
  342. Altering the Composition of Caseicins A and B as a Means of Determining the Contribution of Specific Residues to Antimicrobial Activity
  343. Real-Time PCR Assay To Differentiate Listeriolysin S-Positive and -Negative Strains ofListeria monocytogenes
  344. The gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs
  345. The dawning of a ‘Golden era’ in lantibiotic bioengineering
  346. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
  347. Effect of Bioengineering Lacticin 3147 Lanthionine Bridges on Specific Activity and Resistance to Heat and Proteases
  348. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z
  349. Investigating the importance of charged residues in lantibiotics
  350. TelA Contributes to the Innate Resistance of Listeria monocytogenes to Nisin and Other Cell Wall-Acting Antibiotics
  351. Glutamate Decarboxylase-Mediated Nisin Resistance in Listeria monocytogenes
  352. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria
  353. The ABC Transporter AnrAB Contributes to the Innate Resistance of Listeria monocytogenes to Nisin, Bacitracin, and Various β-Lactam Antibiotics
  354. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
  355. Synthesis of Trypsin-Resistant Variants of the Listeria-Active Bacteriocin Salivaricin P
  356. Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
  357. In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria
  358. Production of the Bsa Lantibiotic by Community-Acquired Staphylococcus aureus Strains
  359. Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147
  360. Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM Proteins
  361. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species
  362. Discovery of Medically Significant Lantibiotics
  363. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147
  364. Isolation and Analysis of Bacteria with Antimicrobial Activities from the Marine Sponge Haliclona simulans Collected from Irish Waters
  365. Listeriolysin S, a Novel Peptide Haemolysin Associated with a Subset of Lineage I Listeria monocytogenes
  366. The generation of nisin variants with enhanced activity against specific Gram-positive pathogens
  367. Controlling Listeria monocytogenes in Cottage cheese through heterologous production of enterocin A by Lactococcus lactis
  368. Lantibiotic Immunity
  369. Two-Peptide Lantibiotics: A Medical Perspective
  370. A System for the Random Mutagenesis of the Two-Peptide Lantibiotic Lacticin 3147: Analysis of Mutants Producing Reduced Antibacterial Activities
  371. The glutamate decarboxylase acid resistance mechanism affects survival of Listeria monocytogenes LO28 in modified atmosphere-packaged foods
  372. Insertional Mutagenesis To Generate Lantibiotic Resistance in Lactococcus lactis
  373. Identification of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphileBacillus haloduransC-125
  374. Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
  375. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design
  376. Bacteriocins: Biological tools for bio-preservation and shelf-life extension
  377. Contribution of Penicillin-Binding Protein Homologs to Antibiotic Resistance, Cell Morphology, and Virulence of Listeria monocytogenes EGDe
  378. Spontaneous resistance inLactococcus lactisIL1403 to the lantibiotic lacticin 3147
  379. Overproduction of Wild-Type and Bioengineered Derivatives of the Lantibiotic Lacticin 3147
  380. Posttranslational conversion of l -serines to d -alanines is vital for optimal production and activity of the lantibiotic lacticin 3147
  381. Food Microbiology: Bacteriocins: developing innate immunity for food
  382. Sequential Actions of the Two Component Peptides of the Lantibiotic Lacticin 3147 Explain Its Antimicrobial Activity at Nanomolar Concentrations
  383. Presence of GadD1 Glutamate Decarboxylase in Selected Listeria monocytogenes Strains Is Associated with an Ability To Grow at Low pH
  384. Microbial solutions to microbial problems; lactococcal bacteriocins for the control of undesirable biota in food
  385. Bacterial Lantibiotics: Strategies to Improve Therapeutic Potential
  386. Structural Characterization of Lacticin 3147, a Two-Peptide Lantibiotic with Synergistic Activity†
  387. Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH
  388. A Food-Grade Approach for Functional Analysis and Modification of Native Plasmids in Lactococcus lactis
  389. The LisRK Signal Transduction System Determines the Sensitivity of Listeria monocytogenes to Nisin and Cephalosporins
  390. Bacterial stress response in Listeria monocytogenes: jumping the hurdles imposed by minimal processing
  391. Role of the Glutamate Decarboxylase Acid Resistance System in the Survival of Listeria monocytogenes LO28 in Low pH Foods
  392. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid
  393. Analysis of the role of the Listeria monocytogenes F0F1-ATPase operon in the acid tolerance response
  394. Applications of Lactic Acid Bacteria-Produced Bacteriocins